Literature DB >> 30695086

Long-Term Effectiveness of Extra-Short (≤ 6 mm) Dental Implants: A Systematic Review

Andrea Ravidà, Shayan Barootchi, Houssam Askar, Fernando Suárez-López Del Amo, Lorenzo Tavelli, Hom-Lay Wang.   

Abstract

PURPOSE: This systematic review evaluated the mean survival rate and marginal bone loss (MBL) of dental implants with ≤ 6 mm in length, across a time frame of 5 years. The overall prosthetic and biologic complications were evaluated, and their survival rates obtained. In addition, the complication rates of the splinted vs nonsplinted implants were assessed.
MATERIALS AND METHODS: An electronic literature search in PubMed (MEDLINE) and EMBASE (OVID) and Cochrane were performed, in addition to a manual search through all periodontics and implantology-related journals, up to October 2017, to identify relevant articles.
RESULTS: Out of 515 potentially eligible articles, 19 investigations assessing a total of 910 extra-short (≤ 6 mm) implants were included and further evaluated. After 5 years of follow-up, a mean survival rate of 94.1% (90% in the maxilla and 96% in the mandible) and a maximum bone loss of 0.53 mm were demonstrated. Additionally, a statistically significant difference in terms of bone loss was observed between tissue-level (0.12 mm) and bone-level implants (0.36 mm) at 12 months (P < .01), but not between internal and external abutment connections (P = .17). The most commonly reported prosthetic complication was screw loosening. Finally, splinted implants showed less overall prosthetic complications (RR = 3.32; 95% CI: 1.9 to 5.7), screw loosening (RR = 15.2; 95% CI: 5.92 to 39.31), and implant failure (RR = 1.96; 95% CI: 0.8 to 4.8) than nonsplinted implants.
CONCLUSION: Extra-short implants are a viable treatment alternative in ridges exhibiting atrophy, demonstrating a satisfactory survival rate, as well as a low rate of prosthetic and biologic complications across a 5-year follow-up. Additionally, splinting extra-short implants is associated with fewer prosthetic complications and lower implant failure rate compared with nonsplinted implants.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30695086     DOI: 10.11607/jomi.6893

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Implants        ISSN: 0882-2786            Impact factor:   2.804


  5 in total

Review 1.  Quality assessment of systematic reviews regarding the effectiveness of zygomatic implants: an overview of systematic reviews.

Authors:  P-H Sales; M-V Gomes; O-B Oliveira-Neto; F-J de Lima; J-C Leão
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-07-01

2.  Survival Rate of 1008 Short Dental Implants with 21 Months of Average Follow-Up: A Retrospective Study.

Authors:  João Caramês; Ana Catarina Pinto; Gonçalo Caramês; Helena Francisco; Joana Fialho; Duarte Marques
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

3.  Comparative Analysis of Peri-Implant Bone Loss in Extra-Short, Short, and Conventional Implants. A 3-Year Retrospective Study.

Authors:  Daycelí Estévez-Pérez; Naia Bustamante-Hernández; Carlos Labaig-Rueda; María Fernanda Solá-Ruíz; José Amengual-Lorenzo; Fernando García-Sala Bonmatí; Álvaro Zubizarreta-Macho; Rubén Agustín-Panadero
Journal:  Int J Environ Res Public Health       Date:  2020-12-11       Impact factor: 3.390

4.  Short Dental Implants (≤8.5 mm) versus Standard Dental Implants (≥10 mm): A One-Year Post-Loading Prospective Observational Study.

Authors:  Guillermo Pardo-Zamora; Antonio José Ortiz-Ruíz; Fabio Camacho-Alonso; José Francisco Martínez-Marco; Juan Manuel Molina-González; Núria Piqué-Clusella; Ascensión Vicente-Hernández
Journal:  Int J Environ Res Public Health       Date:  2021-05-26       Impact factor: 3.390

5.  Five Years Follow-up of Short Implants Placed in Atrophic Maxilla with Simultaneous Sinus Floor Transcrestal Elevation.

Authors:  Stefano Carelli; Alfredo Passaretti; Giulia Petroni; Alessio Zanza; Luca Testarelli; Andrea Cicconetti
Journal:  Acta Stomatol Croat       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.